Cheung, Ning
Duke-NUS Medical School,
Singapore
2025 Rank: 65637
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 309 out of 81681 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65637 | 76423 |
| Total Cites | 1414 | 1439 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 472 | 474 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 474 | 477 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1197 | 1215 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.18 |
| Self-Citation Percentage |
1.74%
|
|
Cheung, Ning
Singapore National Eye Centre,
Singapore
2024 Rank: 70841
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 353 out of 77284 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70841 | 75204 |
| Total Cites | 1286 | 1327 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 457 | 463 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 461 | 467 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1089 | 1118 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.19 |
| Self-Citation Percentage |
3.09%
|
|
Cheung, Ning
Singapore Eye Research Institute,
Singapore
2023 Rank: 72398
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 390 out of 72989 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72398 | 76097 |
| Total Cites | 1105 | 1191 |
| H-index | 13 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 508 | 528 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 518 | 538 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 935 | 983 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.21 |
| Self-Citation Percentage |
7.22%
|
|
Cheung, Ning
Singapore Eye Research Institute,
Singapore
2022 Rank: 72319
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 393 out of 69077 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72319 | 69717 |
| Total Cites | 921 | 1007 |
| H-index | 12 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 467 | 494 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 472 | 500 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 795 | 845 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
8.54%
|
|
Cheung, Ning
Singapore Eye Research Institute,
Singapore
2021 Rank: 81319
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 445 out of 65331 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81319 | 83524 |
| Total Cites | 1240 | 1403 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 619 | 666 |
| Number of Single+First+Last Authored Papers | 58 | 58 |
| Total Cites to Single+First+Last Authored Papers | 625 | 675 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1048 | 1144 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.23 |
| Self-Citation Percentage |
11.62%
|
|
Cheung, Ning
Singapore Eye Research Institute,
Singapore
2020 Rank: 102181
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 527 out of 52338 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102181 | 102744 |
| Total Cites | 798 | 901 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 357 | 389 |
| Number of Single+First+Last Authored Papers | 58 | 58 |
| Total Cites to Single+First+Last Authored Papers | 365 | 397 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 637 | 690 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.31 |
| Self-Citation Percentage |
11.43%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.